Plasma-fibroblast gel as scaffold for islet transplantation

Tissue Engineering - Part A

Volumn 15, Issue 3, 2009, Pages 569-577

  Perez Basterrechea, Marcos ^a,b   Briones, Ruben M ^a   Alvarez Viejo, Maria ^a   Garcia Perez, Eva ^c   Esteban, Manuel M ^b   Garcia, Veronica ^c   Obaya, Alvaro J ^b   Barneo, Luis ^d   Meana, Alvaro ^c,e   Otero, Jesus ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c Centro Comunitario de Sangre y Tejidos Del Principado de Asturias (CCST)   (Spain)

^d HUCA   (Spain)

^e CIEMAT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BLOOD; CELL CULTURE; FIBROBLASTS; GELATION; GELS; GLUCOSE; PLASMAS; SCAFFOLDS; SUGAR (SUCROSE); TISSUE; TRANSPLANTATION (SURGICAL);

ATHYMIC MICE; BLOOD GLUCOSE LEVEL; BLOOD PLASMA; BODY WEIGHT; CLINICAL PRACTICES; COLLAGEN FIBER; CONTROL GROUPS; ENGRAFTMENT; HISTOLOGICAL EVALUATION; ISLET TRANSPLANTATION; KIDNEY CAPSULES; NORMOGLYCEMIA; PANCREATIC ISLET; SUBCUTANEOUS TISSUES; TYPE I DIABETES;

BLOOD VESSELS;

COLLAGEN FIBER; GLUCOSE; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT; BLOOD VESSEL; BODY WEIGHT; CONTROLLED STUDY; FIBROBLAST; GEL; GLUCOSE BLOOD LEVEL; HISTOLOGY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS ISLET TRANSPLANTATION; PLASMA; PRIORITY JOURNAL; RAT; SUBCUTANEOUS TISSUE; ANIMAL; AREA UNDER THE CURVE; BLOOD; CYTOLOGY; DIABETES MELLITUS; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; PANCREAS ISLET; PATHOLOGY; SURVIVAL; TIME; WISTAR RAT;

ANIMALIA; MUS;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS; FASTING; FIBROBLASTS; GELS; GLUCOSE TOLERANCE TEST; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; PLASMA; RATS; RATS, WISTAR; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 64549146303     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0088     Document Type: Article

References (45)

1. Hering, B.J., Kandaswamy, R., Ansite, J.D., Eckman, P.M., Nakano, M., Sawada, T., Matsumoto, I., Ihm, S.H., Zhang, H.J., Parkey, J., Hunter, D.W., and Sutherland, D.E. Singledonor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293, 830, 2005.
2. Robertson, R.P. Islet transplantation as a treatment for diabetes-a work in progress. N Engl J Med 350, 694, 2004.
3. Ryan, E.A., Paty, B.W., Senior, P.A., Bigam, D., Alfadhli, E., Kneteman, N.M., Lakey, J.R., and Shapiro, A.M. Five-year follow-up after clinical islet transplantation. Diabetes 54,2060, 2005.
4. Shapiro, A.M., Lakey, J.R., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M., and Rajotte, R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343, 230, 2000.
5. Pileggi, A., Ricordi, C., Alessiani, M., and Inverardi, L. Factors influencing islet of Langerhans graft function and monitoring. Clin Chim Acta 310, 3, 2001.
6. Shapiro, A.M., Gallant, H.L., Hao, E.G., Lakey, J.R., McCready, T., Rajotte, R.V., Yatscoff, R.W., and Kneteman, N.M. The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit 27, 35, 2005.
7. Bennet, W., Sundberg, B., Groth, C.G., Brendel, M.D., Brandhorst, D., Brandhorst, H., Bretzel, R.G., Elgue, G., Larsson, R., Nilsson, B., and Korsgren, O. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48, 1907, 1999.
8. Guan, J., Behme, M.T., Zucker, P., Atkison, P., Hramiak, I., Zhong, R., and Dupre, J. Glucose turnover and insulin sensitivity in rats with pancreatic islet transplants. Diabetes 47,1020, 1998.
9. Hiller, W.F., Klempnauer, J., Luck, R., and Steiniger, B. Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes 40, 134, 1991.
10. Jansson, L., and Carlsson, P.O. Graft vascular function after transplantation of pancreatic islets. Diabetologia 45, 749, 2002.
11. Rosenberg, L., Wang, R., Paraskevas, S., and Maysinger, D. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 126, 393, 1999.
12. Wang, R.N., and Rosenberg, L. Maintenance of beta-cell function and survival following islet isolation requires reestablishment of the islet-matrix relationship. J Endocrinol 163, 181, 1999.
13. Bharat, A., Benshoff, N., Olack, B., Ramachandran, S., Desai, N.M., and Mohanakumar, T. Novel in vivo murine model to study islet potency: engraftment and function. Transplantation 79, 1627, 2005.
14. Dufour, J.M., Rajotte, R.V., Zimmerman, M., Rezania, A., Kin, T., Dixon, D.E., and Korbutt, G.S. Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng 11, 1323, 2005.
15. Juang, J.H., Bonner-Weir, S., Ogawa, Y., Vacanti, J.P., and Weir, G.C. Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 61, 1557, 1996.
16. Prokop, A., Kozlov, E., Nun Non, S., Dikov, M.M., Sephel, G.C., Whitsitt, J.S., and Davidson, J.M. Towards retrievable vascularized bioartificial pancreas: induction and longlasting stability of polymeric mesh implant vascularized with the help of acidic and basic fibroblast growth factors and hydrogel coating. Diabetes Technol Ther 3, 245, 2001.
17. Tabata, Y., Hijikata, S., Muniruzzaman, M., and Ikada, Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10, 79, 1999.
18. Lacy, P.E., Hegre, O.D., Gerasimidi-Vazeou, A., Gentile, F.T., and Dionne, K.E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254, 1782, 1991.
19. Tatarkiewicz, K., Hollister-Lock, J., Quickel, R.R., Colton, C.K., Bonner-Weir, S., and Weir, G.C. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. Transplantation 67, 665, 1999.
20. Wang, W., Gu, Y., Tabata, Y., Miyamoto, M., Hori, H., Nagata, N., Touma, M., Balamurugan, A.N., Kawakami, Y., Nozawa, M., and Inoue, K. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 73, 122, 2002.
21. Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R., and Rusnati, M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16, 159, 2005.
22. Stock, U.A., and Vacanti, J.P. Tissue engineering: current state and prospects. Annu Rev Med 52, 443, 2001.
23. Currie, L.J., Sharpe, J.R., and Martin, R. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg 108, 1713, 2001.
24. Amory, B., Mourmeaux, J.L., and Remacle, C. In vitro cytodifferentiation of perinatal rat islet cells within a tridimensional matrix of collagen. In Vitro Cell Dev Biol 24, 91, 1988.
25. Beattie, G.M., Montgomery, A.M., Lopez, A.D., Hao, E., Perez, B., Just, M.L., Lakey, J.R., Hart, M.E., and Hayek, A. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 51, 3435, 2002.
26. Brendel, M.D., Kong, S.S., Alejandro, R., and Mintz, D.H. Improved functional survival of human islets of Langerhans in three-dimensional matrix culture. Cell Transplant 3, 427, 1994.
27. Abraham, D.J., Eckes, B., Rajkumar, V., and Krieg, T. New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9, 136, 2007.
28. Liu, H., Chen, B., and Lilly, B. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis 2008. http://dx.doi.org/10.1007/s10456-008-9102-8.
29. van der Vliet, J.A., Meloche, R.M., Field, M.J., Chen, D.J., Kaufman, D.B., and Sutherland, DE. Pancreatic islet isolation in rats with ductal collagenase distention, stationary digestion, and dextran separation. Transplantation 45, 493, 1988.
30. Potteiger, J.A., Jacobsen, D.J., and Donnelly, J.E. A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults. Int J Obes Relat Metab Disord 26, 87, 2002.
31. Purves, R.D. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-underthe-moment-curve (AUMC). J Pharmacokinet Biopharm 20,211, 1992.
32. Gu, Y., Tabata, Y., Kawakami, Y., Balamurugan, A.N., Hori, H., Nagata, N., Satake, A., Cui, W., Qi, M., Misawa, Y., Toma, M., Miyamoto, M., Nozawa, M., and Inoue, K. Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation. Cell Transplant 10, 453, 2001.
33. Wong, T., McGrath, J.A., and Navsaria, H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 156, 1149, 2007.
34. Ruiter, D., Bogenrieder, T., Elder, D., and Herlyn, M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol 3, 35, 2002.
35. Bikfalvi, A., Klein, S., Pintucci, G., and Rifkin, D.B. Biological roles of fibroblast growth factor-2. Endocr Rev 18, 26, 1997.
36. Asahara, T., Bauters, C., Zheng, L.P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J.F., and Isner, J.M. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92,II365, 1995.
37. Ihara, N., Suzuki, K., Tanaka, H., Nakamura, Y., Tanabe, J., Fukuda, A., Fujii, C., Kohama, A., Hamanaka, T., and Tani, T. Application of fibrin glue to burns. Its haemostatic and skin transplant fixation effects in the excised wound. Burns Incl Therm Inj 10, 396, 1984.
38. Gorodetsky, R., Vexler, A., Levdansky, L., and Marx, G. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. Methods Mol Biol 238, 11, 2004.
39. Meana, A., Iglesias, J., Del Rio, M., Larcher, F., Madrigal, B., Fresno, M.F., Martin, C., San Roman, F., and Tevar, F. Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns 24, 621, 1998.
40. Eyrich, D., Wiese, H., Maier, G., Skodacek, D., Appel, B., Sarhan, H., Tessmar, J., Staudenmaier, R., Wenzel, M.M., Goepferich, A., and Blunk, T. In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Eng 13, 2207, 2007.
41. Kneser, U., Voogd, A., Ohnolz, J., Buettner, O., Stangenberg, L., Zhang, Y.H., Stark, G.B., and Schaefer, D.J. Fibrin gelimmobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute. Cells Tissues Organs 179, 158, 2005.
42. Andrades, P., Asiedu, C., Rodriguez, C., Goodwin, K.J., McCarn, J., and Thomas, J.M. Subcutaneous pancreatic islet transplantation using fibrin glue as a carrier. Transplant Proc 39, 191, 2007.
43. Llames, S.G., Del Rio, M., Larcher, F., Garcia, E., Garcia, M., Escamez, M.J., Jorcano, J.L., Holguin, P., and Meana, A. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation 77, 350, 2004.
44. Noel, D., Djouad, F., Bouffi, C., Mrugala, D., and Jorgensen, C. Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 48, 1283, 2007.
45. Rouabhia, M. Damaged skin replacement using Tissue Engineering: chimeric (syngeneic-xenogeneic) epidermal substitute production and grafting. In: Rouabhia, M., ed. Skin Substitute Production by Tissue Engineering. Austin, TX: R.G. Landes Company, 1997, pp. 131-151.